Orthopedics News: Breaking Orthopedics News, Comments and Articles. - Page: 5

08:34 EDT 30th May 2015 | BioPortfolio

Orthopedics News - Page: 5Twitter RSS

Read the latest Orthopedics News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Orthopedics.

Search or Follow Our Orthopedics - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Orthopedics - Page: 5 News.
You can also follow our Orthopedics - Page: 5 news stories on Twitter: @Orthopedics_Bio

Showing "orthopedics musculoskeletal joints ligaments tendons" News Articles 101 to 125 of 1,300+

Monday 18th May 2015

New Vitality Health Foods, Inc. Provides Tips on How to Recognize Seemingly Unrelated Symptoms of Celiac Disease and the Resulted Diagnostic Challenge

Celiac disease in both adults and children presents in a myriad of ways that extend beyond the digestive system. Orland Park, IL (PRWEB) May 18, 2015 “One of the most frequent misconceptions related to Celiac disease is that it is a condition solely linked to the digestive system,” explained Diana Sourek, MS, CNC, Certified Gluten Practitioner and manager of New Vitality Health Foods, Inc. ...

Good Samaritan Hospital Offers an Alternative to Long-Term Warfarin Medication for Atrial Fibrillation with Newly Approved Watchman™ LAAC Implant

LOS ANGELES, May 18, 2015 /PRNewswire-USNewswire/ -- Good Samaritan Hospital is one of the first hospitals in California to offer patients with non-valvular atrial fibrillation (a-fib) an alternative to long-term warfarin medication with the newly approved Watchman™ Left Atrial Appendage Closure (LAAC) Implant. For patients with atrial fibrillation who are considered suitable for warfarin b...

Roadmap for the Revitalization of Catheter-Based Renal Sympathetic Denervation Related to Clinically Meaningful, Optimized Device Design: CBSET to Present Compelling Preclinical Evidence at EuroPCR 2015

“Renal denervation, despite recent stumbles, is experiencing a resurgence with next-generation device design. CBSET’s incontrovertible mechanistic data provides the pathway for predicting efficacy and designing more efficacious devices and protocols,” said Peter M. Markham, President and CEO, CBSET. Scientists at CBSET, a not-for-profit...

CONMED Corporation to Present at the Jefferies 2015 Healthcare Conference

CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, will present at the Jefferies 2015 Healthcare Conference at 3:30 p.m. ET on Wednesday, June 3, 2015 in New York, NY. A live webcast of CONMED’s presentation will be accessible through the Investors section of the Company’s website at w...

Toronto researchers generate cartilage from human stem cells

SOURCE May 13, 2015 A team of Toronto-based scientists has been able to generate cartilage tissue from human stem cells. The team from the McEwen Centre for Regenerative Medicine was able to direct human stem cells to produce the specific cells that make the cartilage that lines our joints, known […]

International Federation of Psoriasis Associations: A Need for Global Awareness of the Burden of Psoriatic Arthritis

International Federation of Psoriasis Associations publishes issue brief on psoriatic arthritis to raise awareness of its impact on the individual and society Today, in conjunction with the opening of the 68th World Health Assembly, the International Federation of Psoriasis Associations, IFPA, launches an issue brief on psoriatic arthritis, calling the...

Sunday 17th May 2015

Hilterapia®: an Italian Excellence for the Treatment of Tendinitis

VICENA, Italy, May 18, 2015 /PRNewswire/ -- An international scientific research confirms the efficacy of the therapy developed by ASAlaser in treating one of the most common disorders, especially among sportsmen A recent study conducted by the researchers Gabrhel J., Popracová Z., Tauchmannová H. and M. Nemšák on the application of Hilterapia®, produced by ASAlaser - a ...

First Choice Healthcare Reports Profitable Results for First Quarter 2015

MELBOURNE, FL -- (Marketwired) -- 05/18/15 -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"), a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today reported its first quarter financial results for the three months ended March 31, 2015. Financial...

Modernizing Medicine Incorporates American Urological Associations Choosing Wisely Guidelines into Its Electronic Medical Records System

Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, iPad native, specialty-specific electronic medical record (EMR) system, announced today that it has incorporated the American Urological Association’s (AUA) 2013 Choosing Wisely® list in EMA Urology™. This Smart News Release features multimedia...

Saturday 16th May 2015

Medivation and Astellas Announce New Enzalutamide Data Presented at the 2015 American Urology Association Annual Meeting

SAN FRANCISCO, CA and TOKYO, JAPAN -- (Marketwired) -- 05/17/15 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced data from the Phase 2 STRIVE trial comparing enzalutamide and bicalutamide in non-metastatic (M0) and metastatic (M1) prostate cancer patients whose disease progressed despite treatment with a luteinizing hormone-releasing hormone (LHRH) analogue ...

Modernizing Medicine Showcases EMA Gastroenterology EMR System at Annual Digestive Disease Week 2015

Complete with ICD-10, PQRS and built-in medical knowledge to support gastroenterologists Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, iPad native, specialty-specific electronic medical record (EMR) system, will showcase

Friday 15th May 2015

aap: Good start in 2015 with sales and EBITDA increase; growth drivers in Q1 were LOQTEQ® (+ 45%) und Biomaterials (+ 23%)

aap Implantate AG / aap: Good start in 2015 with sales and EBITDA increase; growth drivers in Q1 were LOQTEQ® (+ 45%) und Biomaterials (+ 23%) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. aap Implantate AG (XETRA: AAQ.DE) had a successful start to the 2015 fiscal year, showing growth in sal...

TissueGene, Inc. Announces Special Protocol Assessment (SPA) Agreement with the Food and Drug Administration (FDA) for its Phase 3 Clinical Trial of Invossa™ for Patients Suffering from Osteoarthritis of the Knee

ROCKVILLE, Md., May 15, 2015 /PRNewswire/ -- TissueGene, Inc. announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design, endpoints and statistical analysis plan for a Phase 3 clinical trial for Invossa™, an allogeneic cell therapy for osteoarthritis of the knee.  There are an es...

Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture

DUBLIN, May 15, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced that the U.S. Food and Drug Administration (FDA) has approved a label update for XIAFLEX® (collagenase clostridium histolyticum or CCH) for the treatment of adult Dupuytren's contracture (DC) patients with a palpable cord. The updated label now...

Stress and JIA

A PhD student has started some exciting work looking at whether psychological stress can lead to young people with arthritis suffering flare-ups. Laura Hann's study will hopefully lead to a better understanding of a theory held by some doctors that when young people with juvenile idiopathic arthritis (JIA) suffer stress, for example around the time of exams, it can cause their condition to suddenl...

Modernizing Medicine and Miraca Life Sciences Debut EMA Urology EMR System

Modernizing Medicine®, the creator of the Electronic Medical Assistant® (EMA™) electronic medical record (EMR) system, and Miraca Life Sciences (MLS), the nation’s largest independent anatomic pathology lab, today announced they will debut EMA Urology™, a cloud-based EMR system desi

Grants awarded

Clinical studies Name Institution Grant name Grant awarded

AbbVie Receives Orphan Drug Designation for HUMIRA® (adalimumab) from the U.S. Food and Drug Administration for the Investigational Treatment of Moderate-to-Severe Hidradenitis Suppurativa (HS)

NORTH CHICAGO, Ill., May 15, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has granted HUMIRA® (adalimumab) orphan drug designation for the investigational treatment of moderate-to-severe hidradenitis suppurativa (HS) (Hurley Stage II and Hurley Stage III disease), a painful, chronic inflammatory skin disease. AbbVie's supplemental Bi...

Thursday 14th May 2015

CymaBay to Present at the 2015 UBS Global Healthcare Conference

NEWARK, CA--(Marketwired - May 15, 2015) - CymaBay Therapeutics Inc. (NASDAQ: CBAY) today announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare Conference on Wednesday, May 20, at 9:30 a.m. ET at the Sheraton New York Times Square Hotel in New York City. The presentation will be webcast live and available fo...

The next steps for childhood arthritis

For years teenagers with arthritis were a neglected patient group. They missed out on the chance to take part in important clinical trials that could have led to better care and treatment. And because there were (and still are) very few adolescent rheumatology clinics aimed at their very particular needs, they fell into a gap between childhood and adulthood. The limited knowledge about adolescent...

The next big thing in rheumatoid arthritis research

  It’s almost 20 years since a new class of drugs transformed the treatment of rheumatoid arthritis. Anti-TNF therapy, developed and pioneered by scientists at our Kennedy Institute, has since spawned a generation of biological therapies. It’s not a cure but it can be extraordinarily effective in reducing the symptoms of inflammatory forms of arthritis, including rheumatoid arthri...

Research roundup

Improving surgery for mal-aligned knees Dr Rajshree Mootanah at Anglia Ruskin University has been awarded a £133,430 project grant that will correct ‘mal-alignment’ of the knee joint by improving the effectiveness of realignment surgery. He’ll develop a computer program to predict how much surgical realignment is needed to minimise pressure on the knee joint after surgery....

Tired of fatigue

We all get tired, but the fatigue associated with inflammatory arthritis is more than just tiredness. It’s a feeling of utter weariness that makes the limbs seem heavy, causing exhaustion and affecting concentration and motivation. It can come on for no apparent reason. Chris’s fatigue Chris Dutton, 36, from Whitley Bay, has psoriatic arthritis affecting his knees, feet and elbo...

Work in progress

After 12 years of working in a bank, spending increasingly long hours hand-sorting letters, and having to meet ever-tighter deadlines, Anna was feeling more and more pressured. She developed severe pain in her thumb, which spread up her arm. Her employer’s occupational health team advised her to go to her GP and not return to work until she was fully fit. Her GP prescribed painkillers, gave ...

CreakyJoints Launches “Arthritis Power,” the First Ever Patient-Led, Patient-Centered Research Registry for Arthritis Patients

Forthcoming proprietary mobile app will securely collect data to inform clinical trials and allow patients to track, access and share personal health information with their health care team. CreakyJoints, the online, non-profit, patient support community with more than 80,000 members, today announces the launch of


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks